Impact of Single-Unit Transfusion on Patients Receiving Treatment for Acute Leukemia and Other Hematological Diseases

Red blood cell (RBC) transfusions are a critical component of managing anemia in patients with acute leukemia and other hematological diseases. However, concerns regarding transfusion-related complications, resource utilization, and blood shortages have led to increased interest in restrictive transfusion strategies. This study evaluates the safety and efficacy of a single-unit RBC transfusion strategy compared to the conventional double-unit approach in hematological patients.This study including 200 patients undergoing treatment for acute leukemia or other hematological disorders. Patients were randomly assigned in a 1:1 ratio to receive either single-unit RBC transfusion (n = 100) or double-unit RBC transfusion (n = 100). The primary outcome was the composite incidence of severe complications, including ICU admission and 30-day mortality. Secondary outcomes included post-transfusion hemoglobin levels, transfusion-related adverse events, total RBC usage, hospital stay duration, and quality of life improvements. There were no significant differences between the single-unit and double-unit groups in ICU admission rates (12.3% vs. 11.8%, p = 0.72) or 30-day mortality (7.9% vs. 8.5%, p = 0.64). However, the single-unit group required significantly fewer transfusions (mean: 3.2 vs. 5.6 RBC units per patient, p

Acute leukemia · Blood transfusion · Intensive care medicine · Leukemia · Blood transfusion and management · Hematopoietic Stem Cell Transplantation · Medicine · Neutropenia and Cancer Infections · Psychology · Internal Medicine